Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identifying effective drug combinations for patients with acute myeloid leukemia.

Expert review of anticancer therapy - 1 Jul 2020

Yilmaz Musa, Kadia Tapan, Ravandi Farhad

Abstract excerpt

INTRODUCTION: The development of high-throughput sequencing technologies and the relentless pursuit of quality translational and clinical research allowed us to understand the leukemogenesis driven by recurrent mutations and design targeted therapies. As a result, the landscape of standard acute myeloid leukemia (AML) therapy has remarkably changed; only within the last few years, eight new agents were approved...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Drug Approval

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Development

Share to High-Throughput Nucleotide Sequencing

Share to Leukemia, Myeloid, Acute

Share to Molecular Targeted Therapy

Share to Prognosis

Share to Survival

Source

Identifiers

PMID: 32552126
DOI: 10.1080/14737140.2020.1782749

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identifying effective drug combinations for patients with acute myeloid leukemia.PMID 32552126Read ↗

An Overview of Targeted Therapies in Acute Myeloid LeukemiaSemantic proximity Read ↗

Update on current treatments for adult acute myeloid leukemia: to treat acute myeloid leukemia intensively or non-intensively? That is the question.Semantic proximity Read ↗

New agents for acute myeloid leukemia: is it time for targeted therapies?Semantic proximity Read ↗

Treatment of Acute Myeloid Leukemia in the Era of Genomics—Achievements and Persisting ChallengesSemantic proximity Read ↗

Recent advances in the understanding and treatment of acute myeloid leukemiaSemantic proximity Read ↗

Recent advances in targeted therapies in acute myeloid leukemia.Semantic proximity Read ↗

Cutting Edge Molecular Therapy for Acute Myeloid Leukemia.Semantic proximity Read ↗

Molecularly targeted drug combinations demonstrate selective effectiveness for myeloid- and lymphoid-derived hematologic malignancies.Semantic proximity Read ↗

Novel therapeutic strategies for AML in 2012.Semantic proximity Read ↗

‘Acute myeloid leukemia: a comprehensive review and 2016 update’Semantic proximity Read ↗

Molecular-Targeted Therapy of Pediatric Acute Myeloid Leukemia.Semantic proximity Read ↗

Experimental drugs in clinical trials for acute myeloid leukemia: innovations, trends, and opportunities.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.